On the public citation graph
Preserved β-Cell Function in Type 1 Diabetes by Mesenchymal Stromal Cells
0 signed · 338 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/(sici)1096-9136(199810)15:10<844::aid-dia679>3.0.co;2-aopenalex-snapshot
Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus
inferredcites →https://doi.org/10.1002/stem.1111openalex-snapshot
Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
inferredcites →https://doi.org/10.1002/stem.1118openalex-snapshot
Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue Formation
inferredcites →https://doi.org/10.1007/s00125-012-2719-6openalex-snapshot
Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study
inferredcites →https://doi.org/10.1016/j.bbmt.2011.07.023openalex-snapshot
Long-Term Complications, Immunologic Effects, and Role of Passage for Outcome in Mesenchymal Stromal Cell Therapy
inferredcites →https://doi.org/10.1016/j.exphem.2007.11.007openalex-snapshot
Mesenchymal cells recruit and regulate T regulatory cells
inferredcites →https://doi.org/10.1016/s0140-6736(04)16104-7openalex-snapshot
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells
inferredcites →https://doi.org/10.1016/s0140-6736(08)60690-xopenalex-snapshot
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
inferredcites →https://doi.org/10.1056/nejmoa061267openalex-snapshot
International Trial of the Edmonton Protocol for Islet Transplantation
inferredcites →https://doi.org/10.1073/pnas.0608249103openalex-snapshot
Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/ scid mice
inferredcites →https://doi.org/10.1089/scd.2010.0009openalex-snapshot
Persistent High Glucose Concentrations Alter the Regenerative Potential of Mesenchymal Stem Cells
inferredcites →https://doi.org/10.1111/cei.12085openalex-snapshot
Progress in immune-based therapies for type 1 diabetes
inferredcites →https://doi.org/10.1182/blood-2003-11-3909openalex-snapshot
Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase–mediated tryptophan degradation
inferredcites →https://doi.org/10.1182/blood-2006-02-002246openalex-snapshot
Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
inferredcites →https://doi.org/10.1182/blood-2007-02-069716openalex-snapshot
Immunomodulatory properties of mesenchymal stromal cells
inferredcites →https://doi.org/10.1182/blood-2007-02-075481openalex-snapshot
A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells
inferredcites →https://doi.org/10.1634/stemcells.2007-0737openalex-snapshot
The Anti-Inflammatory and Anti-Angiogenic Role of Mesenchymal Stem Cells in Corneal Wound Healing Following Chemical Injury
inferredcites →https://doi.org/10.2337/db08-0180openalex-snapshot
Immunomodulation by Mesenchymal Stem Cells
inferredcites →https://doi.org/10.2337/db09-0317openalex-snapshot
Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and -9
inferredcites →https://doi.org/10.2337/db10-0542openalex-snapshot
Congenic Mesenchymal Stem Cell Therapy Reverses Hyperglycemia in Experimental Type 1 Diabetes
inferredcites →https://doi.org/10.2337/db11-1538openalex-snapshot
Fall in C-Peptide During First 2 Years From Diagnosis
inferredcites →https://doi.org/10.2337/diacare.26.3.832openalex-snapshot
β-Cell Function and the Development of Diabetes-Related Complications in the Diabetes Control and Complications Trial
inferredcites →https://doi.org/10.3389/fimmu.2013.00201openalex-snapshot
Mesenchymal Stem Cells in Tissue Repair
inferredcites →https://doi.org/10.4049/jimmunol.0900803openalex-snapshot
Immunomodulatory Function of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Type 1 Diabetes
inferredcites →https://doi.org/10.4049/jimmunol.0902007openalex-snapshot
Mesenchymal Stem Cells Inhibit Human Th17 Cell Differentiation and Function and Induce a T Regulatory Cell Phenotype
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4675577openalex-extracted
Assessment and Comparing the Effectiveness of Tumor-Induced Mscs on Cell Growth and Development in Different Cancer Types in Vitro and in Vivo
inferred← citeshttps://doi.org/10.1002/adbi.202300107openalex-snapshot
Dissecting the Interrelationship between COVID‐19 and Diabetes Mellitus
inferred← citeshttps://doi.org/10.1002/adma.201804041openalex-snapshot
Minimally Invasive and Regenerative Therapeutics
inferred← citeshttps://doi.org/10.1002/jcp.26860openalex-snapshot
Fibroblasts and mesenchymal stem cells: Two sides of the same coin?
inferred← citeshttps://doi.org/10.1002/mco2.70192openalex-snapshot
Tissue Engineering and Regenerative Medicine: Perspectives and Challenges
inferred← citeshttps://doi.org/10.1002/sctm.17-0005openalex-snapshot
Durable Control of Autoimmune Diabetes in Mice Achieved by Intraperitoneal Transplantation of “Neo-Islets,” Three-Dimensional Aggregates of Allogeneic Islet and “Mesenchymal Stem Cells”
inferred← citeshttps://doi.org/10.1002/sctm.19-0202openalex-snapshot
Trends in mesenchymal stem cell clinical trials 2004-2018: Is efficacy optimal in a narrow dose range?
inferred← citeshttps://doi.org/10.1002/sctm.20-0122openalex-snapshot
Overexpression of alpha-1 antitrypsin in mesenchymal stromal cells improves their intrinsic biological properties and therapeutic effects in nonobese diabetic mice
inferred← citeshttps://doi.org/10.1002/sctm.20-0472openalex-snapshot
Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: A double-blind, phase 1/2a, randomized controlled trial
inferred← citeshttps://doi.org/10.1002/sctm.21-0021openalex-snapshot
Advances in Mesenchymal Stem Cell Therapy for Immune and Inflammatory Diseases: Use of Cell-Free Products and Human pluripotent Stem Cell-Derived Mesenchymal Stem Cells
inferred← citeshttps://doi.org/10.1002/stem.2290openalex-snapshot
Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes
inferred← citeshttps://doi.org/10.1002/stem.2509openalex-snapshot
Mesenchymal Stromal Cell Secretion of Programmed Death-1 Ligands Regulates T Cell Mediated Immunosuppression
inferred← citeshttps://doi.org/10.1007/5584_2019_476openalex-snapshot
Differentiation Potential of Mesenchymal Stem Cells into Pancreatic β-Cells
inferred← citeshttps://doi.org/10.1007/5584_2020_614openalex-snapshot
Conventional and Alternative Mesenchymal Stem Cell Therapies for the Treatment of Diabetes
inferred← citeshttps://doi.org/10.1007/978-3-030-33946-3_3openalex-snapshot
Microbiome and Cellular Players in Type 1 Diabetes: From Pathogenesis to Protection
inferred← citeshttps://doi.org/10.1007/978-3-030-55359-3_1openalex-snapshot
Introduction and Basic Concepts in Stem Cell Research and Therapy: The Facts and the Hype
inferred← citeshttps://doi.org/10.1007/978-3-030-79871-0_9openalex-snapshot
Biomanufacturing of Mesenchymal Stromal Cells for Therapeutic Applications
inferred← citeshttps://doi.org/10.1007/978-3-031-20999-4_56openalex-snapshot
Recurrence of Type 1 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1007/978-3-031-41943-0_23openalex-snapshot
Clinical Trials with Stem Cell-Derived Insulin-Producing Cells
inferred← citeshttps://doi.org/10.1007/978-3-031-41943-0_9openalex-snapshot
3D Organoids of Mesenchymal Stromal and Pancreatic Islet Cells
inferred← citeshttps://doi.org/10.1007/978-3-032-12705-1_6openalex-snapshot
Cell Therapy for Type 1 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1007/978-3-319-45457-3_7openalex-snapshot
Cryopreserved or Fresh Mesenchymal Stromal Cells: Only a Matter of Taste or Key to Unleash the Full Clinical Potential of MSC Therapy?
inferred← citeshttps://doi.org/10.1007/978-981-13-2703-2_9openalex-snapshot
Therapeutic Application of Perinatal Mesenchymal Stem Cells in Diabetes Mellitus
inferred← citeshttps://doi.org/10.1007/978-981-16-1247-3_107-1openalex-snapshot
Mesenchymal Stem Cell Mediated Suicide Gene Therapy
inferred← citeshttps://doi.org/10.1007/978-981-16-5123-6_16openalex-snapshot
Future Therapies for Diabetes
inferred← citeshttps://doi.org/10.1007/978-981-16-5422-0_107openalex-snapshot
Mesenchymal Stem Cell-Mediated Suicide Gene Therapy
inferred← citeshttps://doi.org/10.1007/978-981-96-1261-1_15openalex-snapshot
Cell Therapy for Diabetes Mellitus
inferred← citeshttps://doi.org/10.1007/978-981-99-0846-2_20-1openalex-snapshot
Stem Cell-Based Regenerative Therapies for Functional Endocrine System Organs: Tissue Engineering Applications and Future Strategies
inferred← citeshttps://doi.org/10.1007/978-981-99-7119-0_20openalex-snapshot
Stem Cell-Based Regenerative Therapies for Functional Endocrine System Organs: Tissue Engineering Applications and Future Strategies
inferred← citeshttps://doi.org/10.1007/s00018-017-2473-5openalex-snapshot
Interactions between mesenchymal stem cells and the immune system
inferred← citeshttps://doi.org/10.1007/s00125-015-3808-0openalex-snapshot
Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients
inferred← citeshttps://doi.org/10.1007/s00125-022-05708-3openalex-snapshot
Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade
inferred← citeshttps://doi.org/10.1007/s00125-023-05934-3openalex-snapshot
Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial
inferred← citeshttps://doi.org/10.1007/s00125-025-06634-wopenalex-snapshot
Characterisation of human pancreatic mesenchymal stromal cells in type 1 diabetes
inferred← citeshttps://doi.org/10.1007/s10529-020-02908-yopenalex-snapshot
The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats
inferred← citeshttps://doi.org/10.1007/s10529-020-02975-1openalex-snapshot
Correction to: The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats
inferred← citeshttps://doi.org/10.1007/s10561-024-10128-1openalex-snapshot
Efficacy of mesenchymal stromal cells in the treatment of type 1 diabetes: a systematic review
inferred← citeshttps://doi.org/10.1007/s10853-018-03200-1openalex-snapshot
Preparation of polycarbonate/gelatine microspheres using a high-voltage electrostatic technique for enhancing the adhesion and proliferation of mesenchymal stem cells
inferred← citeshttps://doi.org/10.1007/s11033-022-07194-7openalex-snapshot
Differentiation of multipotent stem cells to insulin-producing cells for treatment of diabetes mellitus: bone marrow- and adipose tissue-derived cells comparison
inferred← citeshttps://doi.org/10.1007/s11154-021-09642-4openalex-snapshot
Diabetes type 1: Can it be treated as an autoimmune disorder?
inferred← citeshttps://doi.org/10.1007/s11892-015-0616-3openalex-snapshot
Mesenchymal Stromal Cells to Halt the Progression of Type 1 Diabetes?
inferred← citeshttps://doi.org/10.1007/s11892-018-1066-5openalex-snapshot
Immune Mechanisms and Pathways Targeted in Type 1 Diabetes
inferred← citeshttps://doi.org/10.1007/s12015-018-9869-yopenalex-snapshot
Impact of Diabetes Mellitus on Human Mesenchymal Stromal Cell Biology and Functionality: Implications for Autologous Transplantation
inferred← citeshttps://doi.org/10.1007/s12015-020-10086-7openalex-snapshot
Neglected No More: Emerging Cellular Therapies in Traumatic Injury
inferred← citeshttps://doi.org/10.1007/s12020-024-03929-7openalex-snapshot
Potentials of bone marrow cells-derived from naïve or diabetic mice in autoimmune type 1 diabetes: immunomodulatory, anti-inflammatory, anti hyperglycemic, and antioxidative
inferred← citeshttps://doi.org/10.1007/s13577-021-00578-0openalex-snapshot
Mesenchymal stem cells: ideal seeds for treating diseases
inferred← citeshttps://doi.org/10.1007/s13577-023-01007-0openalex-snapshot
Treatment of type 2 diabetes mellitus with stem cells and antidiabetic drugs: a dualistic and future-focused approach
inferred← citeshttps://doi.org/10.1007/s13770-018-0143-9openalex-snapshot
Current Status of Stem Cell Treatment for Type I Diabetes Mellitus
inferred← citeshttps://doi.org/10.1007/s40200-020-00602-4openalex-snapshot
The modulation of mature dendritic cells from patients with type 1 diabetes using human periodontal ligament stem cells. An in-vitro study
inferred← citeshttps://doi.org/10.1007/s40200-020-00647-5openalex-snapshot
Therapeutic potential of mesenchymal stem cells in treating both types of diabetes mellitus and associated diseases
inferred← citeshttps://doi.org/10.1007/s40200-022-01120-1openalex-snapshot
Stem cell therapy for type 1 diabetes: a scientometric assessment of global research during the twenty-first century
inferred← citeshttps://doi.org/10.1007/s40200-026-01920-9openalex-snapshot
A systematic review of clinical trials in mesenchymal stem cell therapy for type 1 diabetes mellitus
inferred← citeshttps://doi.org/10.1007/s40265-025-02150-8openalex-snapshot
Emerging Immunotherapies for Disease Modification of Type 1 Diabetes
inferred← citeshttps://doi.org/10.1007/s40472-025-00470-yopenalex-snapshot
State of the Art of Bioengineering Approaches in Beta-Cell Replacement
inferred← citeshttps://doi.org/10.1007/s40618-017-0641-yopenalex-snapshot
Immunotherapy for type 1 diabetes
inferred← citeshttps://doi.org/10.1007/s40620-018-0548-5openalex-snapshot
Infusion of autologous bone marrow derived mononuclear stem cells potentially reduces urinary markers in diabetic nephropathy
inferred← citeshttps://doi.org/10.1016/b978-0-12-809880-6.00021-7openalex-snapshot
From Adult Pancreatic Islets to Stem Cells
inferred← citeshttps://doi.org/10.1016/b978-0-12-809880-6.00056-4openalex-snapshot
Islet Cell Transplantation
inferred← citeshttps://doi.org/10.1016/b978-0-12-811920-4.00010-0openalex-snapshot
Bone Marrow Mesenchymal Stem Cells as a New Therapeutic Approach for Diabetes Mellitus
inferred← citeshttps://doi.org/10.1016/b978-0-12-814833-4.00054-xopenalex-snapshot
Treating diabetes with islet cell transplantation: Lessons from the Edmonton experience
inferred← citeshttps://doi.org/10.1016/b978-0-12-814833-4.00058-7openalex-snapshot
Progress toward islet transplantation tolerance
inferred← citeshttps://doi.org/10.1016/b978-0-12-814833-4.00064-2openalex-snapshot
Cellular therapies in preclinical and clinical islet transplantation: Mesenchymal stem cells
inferred← citeshttps://doi.org/10.1016/b978-0-12-823318-4.00013-5openalex-snapshot
Stem cell therapies in diabetes
inferred← citeshttps://doi.org/10.1016/b978-0-12-824390-9.00014-1openalex-snapshot
New advanced therapy medicinal products in treatment of autoimmune diseases
inferred← citeshttps://doi.org/10.1016/bs.pmbts.2018.07.009openalex-snapshot
Adult Stem Cells for Regenerative Therapy
inferred← citeshttps://doi.org/10.1016/j.arcmed.2025.103212openalex-snapshot
Effectiveness of Tumor-induced Mesenchymal Stem Cells on Cell Growth and Development in Different Cancer Types In Vitro and In Vivo Models
inferred← citeshttps://doi.org/10.1016/j.autrev.2021.102873openalex-snapshot
Safety and immunological proof-of-concept following treatment with tolerance-inducing cell products in patients with autoimmune diseases or receiving organ transplantation: A systematic review and meta-analysis of clinical trials
inferred← citeshttps://doi.org/10.1016/j.bbadis.2018.10.033openalex-snapshot
Mesenchymal stem cells to treat type 1 diabetes
inferred← citeshttps://doi.org/10.1016/j.bbmt.2017.04.006openalex-snapshot
Commentary: Role of Mesenchymal Stromal Cell–Mediated Crosstalk with Macrophages in Graft-versus-Host Disease and Tissue Repair
inferred← citeshttps://doi.org/10.1016/j.biomaterials.2017.11.023openalex-snapshot
Strategies for MSC expansion and MSC-based microtissue for bone regeneration
inferred← citeshttps://doi.org/10.1016/j.biopha.2019.108912openalex-snapshot
Mesenchymal stem cell-associated lncRNA in osteogenic differentiation
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.116033openalex-snapshot
Regulated intestinal microbiota and gut immunity to ameliorate type 1 diabetes mellitus: A novel mechanism for stem cell-based therapy
inferred← citeshttps://doi.org/10.1016/j.cellimm.2017.08.009openalex-snapshot
Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications
inferred← citeshttps://doi.org/10.1016/j.clineuro.2020.105740openalex-snapshot
Research trends of stem cells in ischemic stroke from 1999 to 2018: A bibliometric analysis
inferred← citeshttps://doi.org/10.1016/j.deman.2024.100247openalex-snapshot
Innovative immunotherapies and emerging treatments in type 1 diabetes management
inferred← citeshttps://doi.org/10.1016/j.diabres.2025.112222openalex-snapshot
Regulation of pancreatic β cells by exosomes from different sources
inferred← citeshttps://doi.org/10.1016/j.dsx.2018.06.021openalex-snapshot
Current status of stem cell therapy, scaffolds for the treatment of diabetes mellitus
inferred← citeshttps://doi.org/10.1016/j.eclinm.2019.100249openalex-snapshot
Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1016/j.heliyon.2024.e35372openalex-snapshot
Characterization of MSCs expressing islet neogenesis associated protein (INGAP): INGAP secretion and cell survival in vitro and in vivo
inferred← citeshttps://doi.org/10.1016/j.intimp.2023.110414openalex-snapshot
Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus
inferred← citeshttps://doi.org/10.1016/j.jcyt.2015.12.004openalex-snapshot
Galectin-1 is a local but not systemic immunomodulatory factor in mesenchymal stromal cells
inferred← citeshttps://doi.org/10.1016/j.jcyt.2017.12.001openalex-snapshot
Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome
inferred← citeshttps://doi.org/10.1016/j.jcyt.2021.09.015openalex-snapshot
Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up
inferred← citeshttps://doi.org/10.1016/j.jcyt.2023.04.012openalex-snapshot
Stem cells therapy for diabetes: from past to future
inferred← citeshttps://doi.org/10.1016/j.jcyt.2023.05.009openalex-snapshot
Lysis and phenotypic modulation of mesenchymal stromal cells upon blood contact triggers anti-inflammatory skewing of the peripheral innate immune repertoire
inferred← citeshttps://doi.org/10.1016/j.jdermsci.2014.10.004openalex-snapshot
Bone marrow stromal cells as immunomodulators. A primer for dermatologists
inferred← citeshttps://doi.org/10.1016/j.jprot.2020.104069openalex-snapshot
Proteomic analysis of extracellular vesicles and conditioned medium from human adipose-derived stem/stromal cells and dermal fibroblasts
inferred← citeshttps://doi.org/10.1016/j.lfs.2022.120563openalex-snapshot
The combined therapy of mesenchymal stem cell transplantation and resveratrol for diabetes: Future applications and challenges
inferred← citeshttps://doi.org/10.1016/j.mam.2021.101063openalex-snapshot
Delivery of therapeutic agents and cells to pancreatic islets: Towards a new era in the treatment of diabetes
inferred← citeshttps://doi.org/10.1016/j.metabol.2018.10.005openalex-snapshot
Stem cells in the treatment of diabetes mellitus — Focus on mesenchymal stem cells
inferred← citeshttps://doi.org/10.1016/j.metabol.2026.156748openalex-snapshot
Mesenchymal stem cell therapy for diabetes: clinical evidence, emerging strategies, and future perspectives
inferred← citeshttps://doi.org/10.1016/j.numecd.2017.02.004openalex-snapshot
Stem cells to restore insulin production and cure diabetes
inferred← citeshttps://doi.org/10.1016/j.phrs.2015.02.010openalex-snapshot
Re-engineering islet cell transplantation
inferred← citeshttps://doi.org/10.1016/j.phrs.2015.03.003openalex-snapshot
Immunogenicity of β-cells for autologous transplantation in type 1 diabetes
inferred← citeshttps://doi.org/10.1016/j.regen.2021.100058openalex-snapshot
Augmenting engraftment of beta cell replacement therapies for T1DM
inferred← citeshttps://doi.org/10.1016/j.reth.2021.08.008openalex-snapshot
COVID-19 and the role of stem cells
inferred← citeshttps://doi.org/10.1016/j.tice.2018.12.001openalex-snapshot
Multilineage potential research on pancreatic mesenchymal stem cells of bovine
inferred← citeshttps://doi.org/10.1016/j.tice.2025.103043openalex-snapshot
Mesenchymal stem cell therapy for diabetes: An umbrella review
inferred← citeshttps://doi.org/10.1016/j.yexcr.2019.111642openalex-snapshot
Effects of hyaluronic acid on differentiation of human amniotic epithelial cells and cell-replacement therapy in type 1 diabetic mice
inferred← citeshttps://doi.org/10.1016/j.ymed.2015.06.003openalex-snapshot
10.1016/j.ymed.2015.06.003
inferred← citeshttps://doi.org/10.1016/j.ymthe.2017.12.013openalex-snapshot
IFN-γ and TNF-α Pre-licensing Protects Mesenchymal Stromal Cells from the Pro-inflammatory Effects of Palmitate
inferred← citeshttps://doi.org/10.1016/j.ymthe.2020.06.026openalex-snapshot
Adiponectin Stimulates Exosome Release to Enhance Mesenchymal Stem-Cell-Driven Therapy of Heart Failure in Mice
inferred← citeshttps://doi.org/10.1016/j.ymthe.2026.03.032openalex-snapshot
Taming autoimmunity: Alpha-1 antitrypsin overexpressing mesenchymal stromal cells promote regulatory T cell crosstalk to reverse diabetes
inferred← citeshttps://doi.org/10.1016/s1957-2557(15)30083-3openalex-snapshot
Autotransplantation de cellules souches mésenchymateuses et diabète de type 1
inferred← citeshttps://doi.org/10.1017/9781316335727.053openalex-snapshot
Hematopoietic Cell Transplants for Non-Neoplastic Diseases
inferred← citeshttps://doi.org/10.1017/9781316335727.058openalex-snapshot
Autologous Hematopoietic Cell Transplants for Autoimmune Diseases: Specific Diseases and Controversies
inferred← citeshttps://doi.org/10.1038/nrendo.2014.172openalex-snapshot
MSC transplant prevents β-cell dysfunction
inferred← citeshttps://doi.org/10.1038/s41392-022-01134-4openalex-snapshot
Stem cell-based therapy for human diseases
inferred← citeshttps://doi.org/10.1038/s41392-025-02313-9openalex-snapshot
Mesenchymal stem cells in treating human diseases: molecular mechanisms and clinical studies
inferred← citeshttps://doi.org/10.1038/s41419-025-08175-xopenalex-snapshot
MSCs ameliorates hyperglycemia-induced endothelial injury through modulation of mitochondrial dynamics
inferred← citeshttps://doi.org/10.1038/s41467-022-28338-0openalex-snapshot
Mesenchymal stem cells transfer mitochondria to allogeneic Tregs in an HLA-dependent manner improving their immunosuppressive activity
inferred← citeshttps://doi.org/10.1038/s41536-026-00454-1openalex-snapshot
CD73 overexpression in ADSCs accelerates bladder repair by regulating the NFκB/NLRP3/caspase-1 signaling axis in neurogenic bladder rats
inferred← citeshttps://doi.org/10.1038/s41598-017-14979-5openalex-snapshot
Human Gingiva-Derived Mesenchymal Stem Cells Ameliorate Streptozoticin-induced T1DM in mice via Suppression of T effector cells and Up-regulating Treg Subsets
inferred← citeshttps://doi.org/10.1038/s41598-024-84574-yopenalex-snapshot
DGCR2 targeting affibody molecules for delivery of drugs and imaging reagents to human beta cells
inferred← citeshttps://doi.org/10.1038/srep37894openalex-snapshot
Infusion with Human Bone Marrow-derived Mesenchymal Stem Cells Improves β-cell Function in Patients and Non-obese Mice with Severe Diabetes
inferred← citeshttps://doi.org/10.1039/d0bm01076fopenalex-snapshot
Efficacy of Fe 3 O 4 @polydopamine nanoparticle-labeled human umbilical cord Wharton's jelly-derived mesenchymal stem cells in the treatment of streptozotocin-induced diabetes in rats
inferred← citeshttps://doi.org/10.1042/etls20210013openalex-snapshot
Mesenchymal stromal cells: what have we learned so far about their therapeutic potential and mechanisms of action?
inferred← citeshttps://doi.org/10.1055/a-0978-4972openalex-snapshot
Safety and Efficacy of Placenta-Derived Mesenchymal Stem Cell Treatment for Diabetic Patients with Critical Limb Ischemia: A Pilot Study
inferred← citeshttps://doi.org/10.1055/a-2094-1039openalex-snapshot
Adipose Tissue-Derived Stromal/Stem Cells Transplantation with Cholecalciferol Supplementation in Recent-Onset Type 1 Diabetes Patients: Twelve Months Follow-Up
inferred← citeshttps://doi.org/10.1055/s-0042-118458openalex-snapshot
Bone Marrow Stromal Stem Cells in Tissue Engineering and Regenerative Medicine
inferred← citeshttps://doi.org/10.1080/09593985.2018.1474511openalex-snapshot
Effects of exercise in combination with autologous bone marrow stem cell transplantation for patients with type 1 diabetes
inferred← citeshttps://doi.org/10.1080/14712598.2020.1748596openalex-snapshot
Cell therapy for type 1 diabetes
inferred← citeshttps://doi.org/10.1089/cell.2022.0039openalex-snapshot
The Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Diabetes Mellitus
inferred← citeshttps://doi.org/10.1089/hum.2015.072openalex-snapshot
Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles
inferred← citeshttps://doi.org/10.1089/scd.2017.0104openalex-snapshot
From “Bench to Bedside”: Current Advancement on Large-Scale Production of Mesenchymal Stem Cells
inferred← citeshttps://doi.org/10.1089/scd.2019.0102openalex-snapshot
Hyaluronan Hydrogels for the Local Delivery of Mesenchymal Stromal Cells to the Injured Vocal Fold
inferred← citeshttps://doi.org/10.1093/jmcb/mjad035openalex-snapshot
Human umbilical cord-derived mesenchymal stem cells alleviate oxidative stress-induced islet impairment via the Nrf2/HO-1 axis
inferred← citeshttps://doi.org/10.1093/stcltm/szad077openalex-snapshot
Clinical Application of Umbilical Cord Mesenchymal Stem Cells Preserves β-cells in Type 1 Diabetes
inferred← citeshttps://doi.org/10.1093/stcltm/szae073openalex-snapshot
Impact of immunosuppressive drugs on efficacy of mesenchymal stem cell therapy for suppressing renal fibrosis
inferred← citeshttps://doi.org/10.1097/cm9.0000000000004150openalex-snapshot
Stem cell therapies for treatment of diabetes mellitus
inferred← citeshttps://doi.org/10.1097/mot.0000000000000359openalex-snapshot
Mesenchymal stem cells to promote islet transplant survival
inferred← citeshttps://doi.org/10.1097/mpa.0000000000001100openalex-snapshot
A Novel Approach for Therapeutic Delivery to the Rodent Pancreas Via Its Arterial Blood Supply
inferred← citeshttps://doi.org/10.1097/ms9.0000000000004147openalex-snapshot
Stem cell therapy: a paradigm shift in reversing type 1 diabetes mellitus
inferred← citeshttps://doi.org/10.1097/pai.0000000000000629openalex-snapshot
Immunohematology Mesenchymal Stromal Cell-based Therapy: From Research to Clinic
inferred← citeshttps://doi.org/10.1097/tp.0000000000001937openalex-snapshot
β Cell Replacement Therapy
inferred← citeshttps://doi.org/10.1101/2022.02.10.479972openalex-snapshot
Identification of CD317-Positive Pro-inflammatory Immune Stromal Cells in Human Mesenchymal Stromal Cell Preparations
inferred← citeshttps://doi.org/10.1101/2025.04.19.649667openalex-snapshot
Alpha-1 Antitrypsin Overexpressing Mesenchymal Stem/Stromal Cells Reverses Type 1 Diabetes via Promoting Treg Function and CD8 + T cell exhaustion
inferred← citeshttps://doi.org/10.1111/1753-0407.12286openalex-snapshot
Therapeutic potential of umbilical cord blood cells for type 1 diabetes mellitus
inferred← citeshttps://doi.org/10.1111/1753-0407.12376openalex-snapshot
Revisiting multiple models of progression of β‐cell loss of function in type 1 diabetes: Significance for prevention and cure
inferred← citeshttps://doi.org/10.1111/ajt.16693openalex-snapshot
Extended survival versus accelerated rejection of nonhuman primate islet allografts: Effect of mesenchymal stem cell source and timing
inferred← citeshttps://doi.org/10.1111/bcp.15100openalex-snapshot
One hundred years since insulin discovery: An update on current and future perspectives for pharmacotherapy of diabetes mellitus
inferred← citeshttps://doi.org/10.1111/bph.15305openalex-snapshot
Developing cell therapies as drug products
inferred← citeshttps://doi.org/10.1111/dom.12556openalex-snapshot
Accessory cells for β‐cell transplantation
inferred← citeshttps://doi.org/10.1111/dom.15375openalex-snapshot
Efficacy of adipose‐derived mesenchymal stem cell therapy in the treatment of chronic micro‐ and macrovascular complications of diabetes
inferred← citeshttps://doi.org/10.1111/jdi.13404openalex-snapshot
Efficacy of mesenchymal stem cell therapy on glucose levels in type 2 diabetes mellitus: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1111/nyas.14904openalex-snapshot
Pathophysiology and management of hypoglycemia in diabetes
inferred← citeshttps://doi.org/10.1136/bmj-2023-075681openalex-snapshot
New advances in type 1 diabetes
inferred← citeshttps://doi.org/10.1155/2015/734731openalex-snapshot
Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century
inferred← citeshttps://doi.org/10.1155/2016/3764681openalex-snapshot
Regenerative Therapy of Type 1 Diabetes Mellitus: From Pancreatic Islet Transplantation to Mesenchymal Stem Cells
inferred← citeshttps://doi.org/10.1155/2019/7219297openalex-snapshot
Enhancing Mesenchymal Stromal Cell Immunomodulation for Treating Conditions Influenced by the Immune System
inferred← citeshttps://doi.org/10.1155/2020/5740923openalex-snapshot
Efficacy and Safety of Stem Cell Therapy for T1DM: An Updated Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1155/2020/5860417openalex-snapshot
Change in Viability and Function of Pancreatic Islets after Coculture with Mesenchymal Stromal Cells: A Systemic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1155/2020/8833725openalex-snapshot
Mesenchymal Stem Cell Therapy for Diabetic Kidney Disease: A Review of the Studies Using Syngeneic, Autologous, Allogeneic, and Xenogeneic Cells
inferred← citeshttps://doi.org/10.1155/2021/9534574openalex-snapshot
Exosomes Secreted by Umbilical Cord Blood-Derived Mesenchymal Stem Cell Attenuate Diabetes in Mice
inferred← citeshttps://doi.org/10.1155/2021/9938658openalex-snapshot
Mesenchymal Stem Cells: An Excellent Candidate for the Treatment of Diabetes Mellitus
inferred← citeshttps://doi.org/10.1155/2022/7829454openalex-snapshot
A Randomized, Controlled Trial Exploring Collaborative Nursing Intervention on Self-Care Ability and Blood Glucose of Patients with Type 2 Diabetes Mellitus
inferred← citeshttps://doi.org/10.1159/000526618openalex-snapshot
Cell Therapy for Type 1 Diabetes: From Islet Transplantation to Stem Cells
inferred← citeshttps://doi.org/10.1161/jaha.121.023491openalex-snapshot
Combination of Antioxidant Enzyme Overexpression and N‐Acetylcysteine Treatment Enhances the Survival of Bone Marrow Mesenchymal Stromal Cells in Ischemic Limb in Mice With Type 2 Diabetes
inferred← citeshttps://doi.org/10.1177/0961203320928419openalex-snapshot
Immunotherapeutic effects of allogeneic mesenchymal stem cells on systemic lupus erythematosus
inferred← citeshttps://doi.org/10.1177/09636897241244943openalex-snapshot
Role of Hedgehog Signaling Pathways in Multipotent Mesenchymal Stem Cells Differentiation
inferred← citeshttps://doi.org/10.1177/1535370219839643openalex-snapshot
Transplantation of neuregulin 4-overexpressing adipose-derived mesenchymal stem cells ameliorates insulin resistance by attenuating hepatic steatosis
inferred← citeshttps://doi.org/10.1186/s11658-025-00786-8openalex-snapshot
Hypoimmune stem cells and islets: hype or a true breakthrough in diabetes treatment?
inferred← citeshttps://doi.org/10.1186/s12916-015-0426-0openalex-snapshot
Mesenchymal stem/stromal cells as a delivery platform in cell and gene therapies
inferred← citeshttps://doi.org/10.1186/s12916-025-04201-zopenalex-snapshot
A systematic review and network meta-analysis of interventions to preserve insulin-secreting beta cell function in people newly diagnosed with type 1 diabetes: results from randomised controlled trials of immunomodulatory therapies
inferred← citeshttps://doi.org/10.1186/s12967-018-1652-yopenalex-snapshot
Tailoring cells for clinical needs: Meeting report from the Advanced Therapy in Healthcare symposium (October 28–29 2017, Doha, Qatar)
inferred← citeshttps://doi.org/10.1186/s12967-024-05226-3openalex-snapshot
Advances and challenges of the cell-based therapies among diabetic patients
inferred← citeshttps://doi.org/10.1186/s13098-025-01619-6openalex-snapshot
Mesenchymal stem cell-based therapy for type 1 & 2 diabetes mellitus patients: a systematic review and meta-analysis of randomized controlled trials
inferred← citeshttps://doi.org/10.1186/s13287-015-0261-4openalex-snapshot
Multipotent mesenchymal stromal cells from patients with newly diagnosed type 1 diabetes mellitus exhibit preserved in vitro and in vivo immunomodulatory properties
inferred← citeshttps://doi.org/10.1186/s13287-017-0511-8openalex-snapshot
CRISPR-targeted genome editing of mesenchymal stem cell-derived therapies for type 1 diabetes: a path to clinical success?
inferred← citeshttps://doi.org/10.1186/s13287-019-1435-2openalex-snapshot
Intra-pancreatic tissue-derived mesenchymal stromal cells: a promising therapeutic potential with anti-inflammatory and pro-angiogenic profiles
inferred← citeshttps://doi.org/10.1186/s13287-020-01793-6openalex-snapshot
Current progress in stem cell therapy for type 1 diabetes mellitus
inferred← citeshttps://doi.org/10.1186/s13287-020-01875-5openalex-snapshot
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
inferred← citeshttps://doi.org/10.1186/s13287-021-02173-4openalex-snapshot
Intrapancreatic MSC transplantation facilitates pancreatic islet regeneration
inferred← citeshttps://doi.org/10.1186/s13287-021-02205-zopenalex-snapshot
Mesenchymal stem cells modified by FGF21 and GLP1 ameliorate lipid metabolism while reducing blood glucose in type 2 diabetic mice
inferred← citeshttps://doi.org/10.1186/s13287-021-02342-5openalex-snapshot
Efficacy of mesenchymal stem cell transplantation therapy for type 1 and type 2 diabetes mellitus: a meta-analysis
inferred← citeshttps://doi.org/10.1186/s13287-021-02417-3openalex-snapshot
One repeated transplantation of allogeneic umbilical cord mesenchymal stromal cells in type 1 diabetes: an open parallel controlled clinical study
inferred← citeshttps://doi.org/10.1186/s13287-022-02782-7openalex-snapshot
Shining the light on clinical application of mesenchymal stem cell therapy in autoimmune diseases
inferred← citeshttps://doi.org/10.1186/s13287-022-02941-wopenalex-snapshot
Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I/II randomized placebo-controlled clinical trial
inferred← citeshttps://doi.org/10.1186/s13287-022-02974-1openalex-snapshot
Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes
inferred← citeshttps://doi.org/10.1186/s13287-022-03028-2openalex-snapshot
Bone marrow mesenchymal stromal cells for diabetes therapy: touch, fuse, and fix?
inferred← citeshttps://doi.org/10.1186/s13287-022-03147-wopenalex-snapshot
Human umbilical cord mesenchymal stem cells ameliorate erectile dysfunction in rats with diabetes mellitus through the attenuation of ferroptosis
inferred← citeshttps://doi.org/10.1186/s13287-024-03636-0openalex-snapshot
Current status of stem cell therapy for type 1 diabetes: a critique and a prospective consideration
inferred← citeshttps://doi.org/10.1186/s13287-024-03885-zopenalex-snapshot
Translational potential of mesenchymal stem cells in regenerative therapies for human diseases: challenges and opportunities
inferred← citeshttps://doi.org/10.1186/s13287-024-03974-zopenalex-snapshot
Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives
inferred← citeshttps://doi.org/10.1186/s13287-025-04377-4openalex-snapshot
A meta-analysis on application and prospect of cell therapy in the treatment of diabetes mellitus
inferred← citeshttps://doi.org/10.1186/s13287-025-04431-1openalex-snapshot
The role and mechanism of mesenchymal stem cells in immunomodulation of type 1 diabetes mellitus and its complications: recent research progress and challenges: a review
inferred← citeshttps://doi.org/10.1186/s13287-025-04807-3openalex-snapshot
Preventing the onset of diabetes with precision delivery of mesenchymal stem cells to the pancreas in a preclinical model
inferred← citeshttps://doi.org/10.1186/s13643-017-0662-9openalex-snapshot
Safety and efficacy of hematopoietic and mesanchymal stem cell therapy for treatment of T1DM: a systematic review and meta-analysis protocol
inferred← citeshttps://doi.org/10.1186/s13643-022-01950-3openalex-snapshot
Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s13643-025-03054-0openalex-snapshot
Efficacy and safety of stem cell therapy in patients with Diabetes Mellitus – a systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1186/s40340-015-0010-9openalex-snapshot
Mesenchymal stromal cells support endothelial cell interactions in an intramuscular islet transplantation model
inferred← citeshttps://doi.org/10.1186/s43045-023-00363-9openalex-snapshot
Cell therapies for autism spectrum disorder: a systematic review of clinical applications
inferred← citeshttps://doi.org/10.1210/clinem/dgad142openalex-snapshot
Adipose-derived Mesenchymal Stem Cells Therapy as a new Treatment Option for Diabetes Mellitus
inferred← citeshttps://doi.org/10.1210/en.2017-00888openalex-snapshot
Transcriptomic Analysis Reveals Novel Mechanisms Mediating Islet Dysfunction in the Intrauterine Growth–Restricted Rat
inferred← citeshttps://doi.org/10.1210/er.2017-00191openalex-snapshot
Obesity in Type 1 Diabetes: Pathophysiology, Clinical Impact, and Mechanisms
inferred← citeshttps://doi.org/10.1210/jc.2014-4070openalex-snapshot
Co-transplantation of Human Pancreatic Islets With Post-migratory Neural Crest Stem Cells Increases β-Cell Proliferation and Vascular And Neural Regrowth
inferred← citeshttps://doi.org/10.1292/jvms.20-0195openalex-snapshot
Efficacy and safety of allogenic canine adipose tissue-derived mesenchymal stem cell therapy for insulin-dependent diabetes mellitus in four dogs: A pilot study
showing the first 200 of 313 · page through all 313
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.